Literature DB >> 25702683

Effects of gestational age at enrollment in pregnancy exposure registries.

Andrea V Margulis1, Murray A Mittleman, Robert J Glynn, Lewis B Holmes, Sonia Hernández-Díaz.   

Abstract

PURPOSE: This study aims to explore the influence of gestational age at enrollment, and enrollment before or after prenatal screening, on the estimation of drug effects in pregnancy exposure registries.
METHODS: We assessed the associations between first trimester antiepileptic drug (AED) exposure and risk of spontaneous abortion and major congenital malformations in the North American AED Registry (1996-2013). We performed logistic regression analyses, conditional or unconditional on gestational age at enrollment, to estimate relative risk (RR) for first trimester AED users compared with non-users. We also compared first trimester users of valproic acid and lamotrigine. Analyses were repeated in women who enrolled before prenatal screening.
RESULTS: Enrollment occurred earlier among 7029 AED users than among 581 non-users; it was similar among AEDs. Comparing AED users with non-users, RR (95% confidence interval) of spontaneous abortion (n = 359) decreased from 5.1 (2.3-14.1) to 2.0 (0.9-5.6) after conditioning on gestational week at enrollment and to 1.9 (0.8-5.4) upon further restriction to before-screening enrollees. RR of congenital malformations (n = 216) changed from 3.1 (1.4-8.5) to 3.2 (1.4-9.0) after conditioning on gestational week at enrollment and to 2.0 (0.7-10.1) upon further restriction to before-screening enrollees. When comparing valproic acid users and lamotrigine users, the RR of congenital malformations was not substantially changed by conditioning or restricting.
CONCLUSIONS: Spontaneous abortion rates were sensitive to gestational age at enrollment. Estimates of congenital malformation risks for AED users relative to non-users were sensitive to before/after-screening enrollment. This difference was not apparent between active drugs, likely due to similar gestational age at enrollment.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  anticonvulsants; left truncation; major congenital malformations; pharmacoepidemiology; pregnancy registries; spontaneous abortions

Mesh:

Substances:

Year:  2015        PMID: 25702683     DOI: 10.1002/pds.3731

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  8 in total

1.  Constructing Causal Diagrams for Common Perinatal Outcomes: Benefits, Limitations and Motivating Examples with Maternal Antidepressant Use in Pregnancy.

Authors:  Gretchen Bandoli; Kristin Palmsten; Katrina F Flores; Christina D Chambers
Journal:  Paediatr Perinat Epidemiol       Date:  2016-05-10       Impact factor: 3.980

2.  Balancing the interests of patient data protection and medication safety monitoring in a public-private partnership.

Authors:  Nancy A Dreyer; Stella Blackburn; Valerie Hliva; Shahrul Mt-Isa; Jonathan Richardson; Anna Jamry-Dziurla; Alison Bourke; Rebecca Johnson
Journal:  JMIR Med Inform       Date:  2015-04-15

3.  Weekly miscarriage rates in a community-based prospective cohort study in rural western Kenya.

Authors:  Stephanie Dellicour; George Aol; Peter Ouma; Nicole Yan; Godfrey Bigogo; Mary J Hamel; Deron C Burton; Martina Oneko; Robert F Breiman; Laurence Slutsker; Daniel Feikin; Simon Kariuki; Frank Odhiambo; Gregory Calip; Andreas Stergachis; Kayla F Laserson; Feiko O ter Kuile; Meghna Desai
Journal:  BMJ Open       Date:  2016-04-15       Impact factor: 2.692

4.  First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies.

Authors:  Stephanie Dellicour; Esperança Sevene; Rose McGready; Halidou Tinto; Dominic Mosha; Christine Manyando; Stephen Rulisa; Meghna Desai; Peter Ouma; Martina Oneko; Anifa Vala; Maria Rupérez; Eusébio Macete; Clara Menéndez; Seydou Nakanabo-Diallo; Adama Kazienga; Innocent Valéa; Gregory Calip; Orvalho Augusto; Blaise Genton; Eric M Njunju; Kerryn A Moore; Umberto d'Alessandro; Francois Nosten; Feiko Ter Kuile; Andy Stergachis
Journal:  PLoS Med       Date:  2017-05-02       Impact factor: 11.069

5.  The German Multiple Sclerosis and Pregnancy Registry: rationale, objective, design, and first results.

Authors:  Sandra Thiel; Andrea I Ciplea; Ralf Gold; Kerstin Hellwig
Journal:  Ther Adv Neurol Disord       Date:  2021-11-22       Impact factor: 6.570

6.  First trimester COVID-19 and the risk of major congenital malformations-International Registry of Coronavirus Exposure in Pregnancy.

Authors:  Sonia Hernández-Díaz; Louisa H Smith; Diego F Wyszynski; Sonja A Rasmussen
Journal:  Birth Defects Res       Date:  2022-08-05       Impact factor: 2.661

7.  Direct-to-Patient Research: Piloting a New Approach to Understanding Drug Safety During Pregnancy.

Authors:  Nancy A Dreyer; Stella Cf Blackburn; Shahrul Mt-Isa; Jonathan L Richardson; Simon Thomas; Maja Laursen; Priscilla Zetstra-van der Woude; Anna Jamry-Dziurla; Valerie Hliva; Alison Bourke; Lolkje de Jong-van den Berg
Journal:  JMIR Public Health Surveill       Date:  2015-12-22

8.  Methods for the assessment of selection bias in drug safety during pregnancy studies using electronic medical data.

Authors:  Mireille E Schnitzer; Lucie Blais
Journal:  Pharmacol Res Perspect       Date:  2018-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.